B-cell Lymphoma  >>  epirubicin  >>  Phase 3
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
epirubicin / Generic mfg.
ANZINTER3, NCT01148446: R-CHOP Versus R-mini-CEOP in Elderly Patients(>65)With DLBCL

Completed
3
226
Europe
Cyclophosphamide, Doxorubicin, Vincristine, Prednisone, Epirubicin, Vinblastine, Rituximab, G-CSF
Fondazione Italiana Linfomi ONLUS
Elderly Patients (>65 Years), Diffuse Large B Cell Lymphoma (DLBCL)
01/06
 
NCT00854568: Comparison Study of Doxorubicin Versus Epirubicin-induced Cardiotoxicity in Patients With DLBCL

Completed
3
398
RoW
CEOP regimen, CEOP, CHOP regimen, CHOP
Fudan University
Lymphoma
12/12
02/13

Download Options